

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51460739 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.51460739 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18581016 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.18581016 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.74792878 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.44628890 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.43940558 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.23936789 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.12063144 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.12063144 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.12063144 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.01028097 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 5.89804229 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.89578246 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.86417110 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.82889855 |
| 17 | * positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.80657703 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.75748125 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.70666365 |
| 20 | urea cycle (GO:0000050) | 5.69857790 |
| 21 | urea metabolic process (GO:0019627) | 5.69857790 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68967643 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.68371820 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.59348452 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54060226 |
| 26 | protein carboxylation (GO:0018214) | 5.50345469 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.50345469 |
| 28 | cysteine metabolic process (GO:0006534) | 5.30713408 |
| 29 | regulation of complement activation (GO:0030449) | 5.26041386 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.25886157 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.23116977 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 5.20809617 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.05866022 |
| 34 | reverse cholesterol transport (GO:0043691) | 5.03263931 |
| 35 | bile acid metabolic process (GO:0008206) | 5.03113611 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.02770713 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 5.00019395 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.94662497 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.92661386 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.92661386 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.92661386 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90207186 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.90009534 |
| 44 | regulation of humoral immune response (GO:0002920) | 4.87338797 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.75661882 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.72105237 |
| 47 | phospholipid efflux (GO:0033700) | 4.71730938 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.68216439 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.68216439 |
| 50 | protein-lipid complex subunit organization (GO:0071825) | 4.64391986 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.58181135 |
| 52 | negative regulation of hemostasis (GO:1900047) | 4.56864043 |
| 53 | negative regulation of blood coagulation (GO:0030195) | 4.56864043 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.55271507 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.55271507 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.54003205 |
| 57 | lysine catabolic process (GO:0006554) | 4.53173376 |
| 58 | lysine metabolic process (GO:0006553) | 4.53173376 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.50366066 |
| 60 | drug metabolic process (GO:0017144) | 4.44579985 |
| 61 | glycine metabolic process (GO:0006544) | 4.36670315 |
| 62 | cholesterol efflux (GO:0033344) | 4.35843763 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.35674712 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.33961411 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.33063691 |
| 66 | coenzyme catabolic process (GO:0009109) | 4.31882021 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.30786369 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.22847944 |
| 69 | amine catabolic process (GO:0009310) | 4.22847944 |
| 70 | glutamate metabolic process (GO:0006536) | 4.21808604 |
| 71 | regulation of apoptotic cell clearance (GO:2000425) | 4.20989611 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.20304773 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.19028319 |
| 74 | fibrinolysis (GO:0042730) | 4.18730780 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 4.15855277 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.13257745 |
| 77 | cellular glucuronidation (GO:0052695) | 4.13169118 |
| 78 | negative regulation of wound healing (GO:0061045) | 4.11425528 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.08245929 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06747691 |
| 81 | blood coagulation, intrinsic pathway (GO:0007597) | 4.05072476 |
| 82 | ethanol metabolic process (GO:0006067) | 4.04498111 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04469377 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 4.02029584 |
| 85 | arginine metabolic process (GO:0006525) | 4.00573534 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 3.99748200 |
| 87 | negative regulation of protein activation cascade (GO:2000258) | 3.96690212 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.96611783 |
| 89 | ethanol oxidation (GO:0006069) | 3.96337428 |
| 90 | oxidative demethylation (GO:0070989) | 3.94878989 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.92388534 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92096728 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92096728 |
| 94 | protein activation cascade (GO:0072376) | 3.91223428 |
| 95 | acute-phase response (GO:0006953) | 3.91015391 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.90408670 |
| 97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.90408670 |
| 98 | positive regulation of hemostasis (GO:1900048) | 3.89997985 |
| 99 | positive regulation of blood coagulation (GO:0030194) | 3.89997985 |
| 100 | complement activation (GO:0006956) | 3.87332893 |
| 101 | lipoprotein metabolic process (GO:0042157) | 3.84666070 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84247589 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.82047415 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.80827403 |
| 105 | drug catabolic process (GO:0042737) | 3.79928558 |
| 106 | cofactor catabolic process (GO:0051187) | 3.79818739 |
| 107 | cholesterol transport (GO:0030301) | 3.79362231 |
| 108 | sterol transport (GO:0015918) | 3.79362231 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.76943168 |
| 110 | ketone body metabolic process (GO:1902224) | 3.76909710 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.76629515 |
| 112 | plasma lipoprotein particle organization (GO:0071827) | 3.75979826 |
| 113 | opsonization (GO:0008228) | 3.74975834 |
| 114 | cytolysis (GO:0019835) | 3.74522824 |
| 115 | negative regulation of complement activation (GO:0045916) | 3.73074192 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.72160503 |
| 117 | sterol homeostasis (GO:0055092) | 3.70351566 |
| 118 | heme transport (GO:0015886) | 3.68705668 |
| 119 | organic acid catabolic process (GO:0016054) | 3.66812141 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 3.66812141 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.66347729 |
| 122 | uronic acid metabolic process (GO:0006063) | 3.65868234 |
| 123 | glucuronate metabolic process (GO:0019585) | 3.65868234 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65402292 |
| 125 | positive regulation of coagulation (GO:0050820) | 3.61662089 |
| 126 | * regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.58498865 |
| 127 | acute inflammatory response (GO:0002526) | 3.56930425 |
| 128 | phenylpropanoid metabolic process (GO:0009698) | 3.54958457 |
| 129 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.44976690 |
| 130 | flavonoid metabolic process (GO:0009812) | 3.39882611 |
| 131 | doxorubicin metabolic process (GO:0044598) | 3.34180770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34641661 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16412498 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02780103 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48097146 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29652212 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.26251687 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81587762 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.12695689 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.10968967 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05485668 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0336508 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99590128 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92975080 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62360382 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56356614 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55398717 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54722638 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40810888 |
| 19 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40784663 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36514009 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25852927 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23267815 |
| 23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21909099 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20104351 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20023661 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18858853 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10220939 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00200521 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97271183 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96810613 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94625923 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90994565 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90757471 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89609583 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83043663 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82948935 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82286122 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80177652 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78995437 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78109242 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77186640 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76836416 |
| 43 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76507663 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74593314 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74143946 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73529909 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73393997 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73261783 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72207588 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72011981 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71812398 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70114660 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 0.68125034 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68044012 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67569939 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67522290 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66861964 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64663118 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64113594 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64113594 |
| 61 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64110885 |
| 62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62032444 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62025080 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60592812 |
| 65 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59695934 |
| 66 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58498037 |
| 67 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.58133063 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57559633 |
| 69 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56255887 |
| 70 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56121083 |
| 71 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.56119459 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.55721694 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55342755 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54365024 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54027254 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54019608 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53614030 |
| 78 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.53582709 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52940344 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52557822 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.52247585 |
| 82 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.52187034 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52163825 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.52152025 |
| 85 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.51680052 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.51596396 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51398936 |
| 88 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.50733532 |
| 89 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50676775 |
| 90 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50384575 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50271583 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.49788154 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.48712358 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.48675192 |
| 95 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.48542995 |
| 96 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48379921 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48157238 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47227157 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.46595762 |
| 100 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46332726 |
| 101 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45679956 |
| 102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.45669640 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45275370 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45081586 |
| 105 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.44901949 |
| 106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44884108 |
| 107 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.44754304 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44416830 |
| 109 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44256519 |
| 110 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44008376 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43193799 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43070041 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42453141 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42087113 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41972149 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41527274 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40868246 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40446561 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39792460 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39748997 |
| 121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39577255 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39394522 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38552646 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38054782 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38019788 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35736359 |
| 127 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.35404368 |
| 128 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34300978 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.34213488 |
| 130 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33611036 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.33385419 |
| 132 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33318466 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33279385 |
| 134 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33255499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21579493 |
| 2 | MP0005360_urolithiasis | 7.50905337 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43352130 |
| 4 | MP0005365_abnormal_bile_salt | 6.15496722 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97803490 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26152297 |
| 7 | MP0003252_abnormal_bile_duct | 3.89342393 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63438293 |
| 9 | MP0009840_abnormal_foam_cell | 3.32369501 |
| 10 | MP0005083_abnormal_biliary_tract | 3.15805814 |
| 11 | MP0003195_calcinosis | 2.85406925 |
| 12 | MP0005332_abnormal_amino_acid | 2.73325734 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59011633 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.57386346 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19604175 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12174166 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10266422 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00749877 |
| 19 | MP0003868_abnormal_feces_composition | 1.87901207 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82682287 |
| 21 | MP0003122_maternal_imprinting | 1.65924129 |
| 22 | MP0001764_abnormal_homeostasis | 1.65274349 |
| 23 | MP0009697_abnormal_copulation | 1.63400321 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56499154 |
| 25 | MP0003011_delayed_dark_adaptation | 1.46400115 |
| 26 | MP0005451_abnormal_body_composition | 1.35041081 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.33316122 |
| 28 | MP0001915_intracranial_hemorrhage | 1.26803852 |
| 29 | MP0003186_abnormal_redox_activity | 1.23391619 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.22985828 |
| 31 | MP0000598_abnormal_liver_morphology | 1.20135115 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.18628467 |
| 33 | MP0000604_amyloidosis | 1.17768568 |
| 34 | MP0005647_abnormal_sex_gland | 1.13727102 |
| 35 | MP0002254_reproductive_system_inflammat | 1.12193236 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.10753873 |
| 37 | MP0009764_decreased_sensitivity_to | 1.09392369 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.07191121 |
| 39 | MP0009763_increased_sensitivity_to | 1.06944165 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.96931892 |
| 41 | MP0003123_paternal_imprinting | 0.90887709 |
| 42 | * MP0008469_abnormal_protein_level | 0.89604618 |
| 43 | MP0002089_abnormal_postnatal_growth/wei | 0.89371429 |
| 44 | MP0004272_abnormal_basement_membrane | 0.88735504 |
| 45 | * MP0009642_abnormal_blood_homeostasis | 0.87784979 |
| 46 | MP0005408_hypopigmentation | 0.83840720 |
| 47 | MP0000566_synostosis | 0.83822466 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.80963170 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.80581899 |
| 50 | MP0005376_homeostasis/metabolism_phenot | 0.80130370 |
| 51 | MP0005670_abnormal_white_adipose | 0.79857969 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.78501891 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.77057461 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.76601967 |
| 55 | MP0002971_abnormal_brown_adipose | 0.73086428 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.72762964 |
| 57 | MP0001661_extended_life_span | 0.70128702 |
| 58 | MP0001986_abnormal_taste_sensitivity | 0.69876767 |
| 59 | MP0009053_abnormal_anal_canal | 0.69776709 |
| 60 | MP0003690_abnormal_glial_cell | 0.69654254 |
| 61 | MP0005334_abnormal_fat_pad | 0.68041112 |
| 62 | MP0003879_abnormal_hair_cell | 0.66225712 |
| 63 | MP0004130_abnormal_muscle_cell | 0.65887139 |
| 64 | MP0005535_abnormal_body_temperature | 0.65299482 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.63050885 |
| 66 | MP0005266_abnormal_metabolism | 0.62604797 |
| 67 | MP0003329_amyloid_beta_deposits | 0.61771321 |
| 68 | MP0002282_abnormal_trachea_morphology | 0.60488800 |
| 69 | MP0006054_spinal_hemorrhage | 0.58380937 |
| 70 | MP0001756_abnormal_urination | 0.58140115 |
| 71 | MP0003941_abnormal_skin_development | 0.57378868 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 0.55126577 |
| 73 | MP0005409_darkened_coat_color | 0.54906821 |
| 74 | MP0005448_abnormal_energy_balance | 0.54606962 |
| 75 | MP0005395_other_phenotype | 0.51890594 |
| 76 | MP0000920_abnormal_myelination | 0.50302927 |
| 77 | MP0003436_decreased_susceptibility_to | 0.48492521 |
| 78 | MP0003724_increased_susceptibility_to | 0.47793800 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.46955480 |
| 80 | MP0003632_abnormal_nervous_system | 0.46580578 |
| 81 | * MP0005464_abnormal_platelet_physiology | 0.46478801 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.46427004 |
| 83 | MP0002928_abnormal_bile_duct | 0.46042816 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.45722180 |
| 85 | MP0005187_abnormal_penis_morphology | 0.45545638 |
| 86 | MP0008873_increased_physiological_sensi | 0.45144185 |
| 87 | MP0003718_maternal_effect | 0.44875103 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.44678623 |
| 89 | MP0002822_catalepsy | 0.43621654 |
| 90 | MP0008874_decreased_physiological_sensi | 0.43369892 |
| 91 | MP0003075_altered_response_to | 0.42624893 |
| 92 | MP0005166_decreased_susceptibility_to | 0.41735811 |
| 93 | MP0000579_abnormal_nail_morphology | 0.41021151 |
| 94 | MP0003953_abnormal_hormone_level | 0.39894255 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.38880984 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.38775612 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.37887956 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.37707664 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.37617235 |
| 100 | MP0004381_abnormal_hair_follicle | 0.36700262 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.36437164 |
| 102 | MP0004883_abnormal_blood_vessel | 0.34734895 |
| 103 | MP0001324_abnormal_eye_pigmentation | 0.34605040 |
| 104 | MP0002796_impaired_skin_barrier | 0.34489291 |
| 105 | MP0009672_abnormal_birth_weight | 0.33932417 |
| 106 | MP0008872_abnormal_physiological_respon | 0.33798923 |
| 107 | MP0000249_abnormal_blood_vessel | 0.33648606 |
| 108 | MP0003633_abnormal_nervous_system | 0.32832237 |
| 109 | MP0009115_abnormal_fat_cell | 0.32291202 |
| 110 | MP0001243_abnormal_dermal_layer | 0.31996397 |
| 111 | MP0001881_abnormal_mammary_gland | 0.31859506 |
| 112 | MP0006082_CNS_inflammation | 0.31840237 |
| 113 | MP0002168_other_aberrant_phenotype | 0.31802534 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.31737491 |
| 115 | MP0002970_abnormal_white_adipose | 0.30106968 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.30065365 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.29856724 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.29843115 |
| 119 | MP0003631_nervous_system_phenotype | 0.29759105 |
| 120 | MP0005410_abnormal_fertilization | 0.29678968 |
| 121 | MP0005164_abnormal_response_to | 0.29373855 |
| 122 | MP0001853_heart_inflammation | 0.29078557 |
| 123 | * MP0002128_abnormal_blood_circulation | 0.28653981 |
| 124 | MP0002090_abnormal_vision | 0.28048274 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.27711848 |
| 126 | MP0002135_abnormal_kidney_morphology | 0.27522063 |
| 127 | MP0002132_abnormal_respiratory_system | 0.27187226 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.27082400 |
| 129 | * MP0003699_abnormal_female_reproductive | 0.26844310 |
| 130 | MP0000371_diluted_coat_color | 0.26681944 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.26644464 |
| 132 | MP0005023_abnormal_wound_healing | 0.26154703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.57919617 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.32347677 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30254450 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.81060499 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65528328 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.45832853 |
| 7 | Xanthomatosis (HP:0000991) | 6.33178289 |
| 8 | Complement deficiency (HP:0004431) | 5.74002506 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.58319187 |
| 10 | Joint hemorrhage (HP:0005261) | 5.00644356 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.90844113 |
| 12 | Hyperammonemia (HP:0001987) | 4.56835487 |
| 13 | Epidermoid cyst (HP:0200040) | 4.53754715 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48290738 |
| 15 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.46962886 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.35178207 |
| 17 | Hyperglycinemia (HP:0002154) | 4.34611256 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.26414184 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22774989 |
| 20 | Abnormality of complement system (HP:0005339) | 4.19922186 |
| 21 | Ketosis (HP:0001946) | 4.17871152 |
| 22 | Fat malabsorption (HP:0002630) | 4.15687299 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11462264 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09635896 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.91358241 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.87642784 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.80915836 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.80915836 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80413152 |
| 30 | Hyperglycinuria (HP:0003108) | 3.78416401 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72994317 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.62762493 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.33912625 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26185685 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23422766 |
| 36 | Steatorrhea (HP:0002570) | 3.09766313 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.06620622 |
| 38 | Myocardial infarction (HP:0001658) | 3.02222229 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.01721548 |
| 40 | Hepatocellular carcinoma (HP:0001402) | 3.01431688 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00340086 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.98457676 |
| 43 | Ketoacidosis (HP:0001993) | 2.95433488 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.87761654 |
| 45 | Skin nodule (HP:0200036) | 2.80054099 |
| 46 | Osteomalacia (HP:0002749) | 2.78388151 |
| 47 | * Spontaneous abortion (HP:0005268) | 2.78055597 |
| 48 | Acanthocytosis (HP:0001927) | 2.70296374 |
| 49 | Metabolic acidosis (HP:0001942) | 2.69719065 |
| 50 | Glomerulonephritis (HP:0000099) | 2.67102976 |
| 51 | Amyloidosis (HP:0011034) | 2.65717671 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.60303553 |
| 53 | Vascular calcification (HP:0004934) | 2.57163735 |
| 54 | Lethargy (HP:0001254) | 2.55483898 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.54154931 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52671383 |
| 57 | Purpura (HP:0000979) | 2.51994448 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.47760627 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47060696 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.47060696 |
| 61 | Spastic diplegia (HP:0001264) | 2.45560057 |
| 62 | Cholelithiasis (HP:0001081) | 2.42668660 |
| 63 | Mitral stenosis (HP:0001718) | 2.41846796 |
| 64 | Cerebral edema (HP:0002181) | 2.38469514 |
| 65 | Gout (HP:0001997) | 2.37968328 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.35418735 |
| 67 | Cholecystitis (HP:0001082) | 2.35418735 |
| 68 | Irritability (HP:0000737) | 2.32231420 |
| 69 | Neonatal onset (HP:0003623) | 2.32068016 |
| 70 | Retinal atrophy (HP:0001105) | 2.28122535 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.28048817 |
| 72 | Abnormal tarsal ossification (HP:0008369) | 2.26546268 |
| 73 | Esophageal varix (HP:0002040) | 2.24978699 |
| 74 | Menorrhagia (HP:0000132) | 2.24461092 |
| 75 | Malnutrition (HP:0004395) | 2.24263257 |
| 76 | Increased serum pyruvate (HP:0003542) | 2.18052653 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.13901174 |
| 78 | Pancreatitis (HP:0001733) | 2.13302793 |
| 79 | Arthropathy (HP:0003040) | 2.12748269 |
| 80 | * Joint swelling (HP:0001386) | 2.12704700 |
| 81 | Poikilocytosis (HP:0004447) | 2.12485368 |
| 82 | Late onset (HP:0003584) | 2.11819390 |
| 83 | Enlarged kidneys (HP:0000105) | 2.10438190 |
| 84 | * Gingival bleeding (HP:0000225) | 2.09928206 |
| 85 | Brushfield spots (HP:0001088) | 2.06522271 |
| 86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06262014 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.03760500 |
| 88 | Vomiting (HP:0002013) | 2.03312061 |
| 89 | * Thrombophlebitis (HP:0004418) | 2.03008262 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.02489638 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 2.01438987 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.00312832 |
| 93 | * Abnormal delivery (HP:0001787) | 1.99721292 |
| 94 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99405211 |
| 95 | Opisthotonus (HP:0002179) | 1.98282725 |
| 96 | Generalized aminoaciduria (HP:0002909) | 1.94331911 |
| 97 | Rickets (HP:0002748) | 1.91301479 |
| 98 | Abnormality of glycolysis (HP:0004366) | 1.89274767 |
| 99 | Glycosuria (HP:0003076) | 1.88241634 |
| 100 | Abnormality of urine glucose concentration (HP:0011016) | 1.88241634 |
| 101 | Nephritis (HP:0000123) | 1.87538496 |
| 102 | Hypophosphatemic rickets (HP:0004912) | 1.86577944 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.83895788 |
| 104 | Elevated alkaline phosphatase (HP:0003155) | 1.83010121 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 1.82674379 |
| 106 | Fair hair (HP:0002286) | 1.81669273 |
| 107 | Increased serum ferritin (HP:0003281) | 1.81606139 |
| 108 | Elevated hepatic transaminases (HP:0002910) | 1.81150567 |
| 109 | * Epistaxis (HP:0000421) | 1.80251533 |
| 110 | Renal cortical cysts (HP:0000803) | 1.79188957 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.78514976 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78389874 |
| 113 | Alkalosis (HP:0001948) | 1.76392486 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.76264756 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.76264756 |
| 116 | Status epilepticus (HP:0002133) | 1.75357702 |
| 117 | Hyperphosphaturia (HP:0003109) | 1.74704126 |
| 118 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74539409 |
| 119 | Hyperglycemia (HP:0003074) | 1.73871204 |
| 120 | Pulmonary embolism (HP:0002204) | 1.72122439 |
| 121 | Proximal tubulopathy (HP:0000114) | 1.71083606 |
| 122 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.64638235 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.57206984 |
| 124 | Potter facies (HP:0002009) | 1.57189841 |
| 125 | Facial shape deformation (HP:0011334) | 1.57189841 |
| 126 | Flat acetabular roof (HP:0003180) | 1.55162213 |
| 127 | Abnormality of the nasal septum (HP:0000419) | 1.46812902 |
| 128 | Hematuria (HP:0000790) | 1.45817639 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 1.45749076 |
| 130 | Hepatoblastoma (HP:0002884) | 1.45098037 |
| 131 | Abnormal hand bone ossification (HP:0010660) | 1.44815509 |
| 132 | Bifid scrotum (HP:0000048) | 1.41877231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.92548658 |
| 2 | PDK2 | 5.71217786 |
| 3 | ERN1 | 4.82216640 |
| 4 | FGFR4 | 4.75866672 |
| 5 | SIK1 | 4.31627385 |
| 6 | ERBB4 | 3.19190834 |
| 7 | TAOK3 | 3.17345001 |
| 8 | INSRR | 3.05397972 |
| 9 | MAP2K4 | 2.30122043 |
| 10 | MST1R | 2.16809158 |
| 11 | WNK4 | 2.07998733 |
| 12 | MAPK11 | 2.02441003 |
| 13 | AKT3 | 2.01091411 |
| 14 | PKN2 | 1.99928246 |
| 15 | PDGFRA | 1.85575545 |
| 16 | PIK3CG | 1.85354382 |
| 17 | TRIB3 | 1.78968375 |
| 18 | TYK2 | 1.78197542 |
| 19 | FLT3 | 1.76436729 |
| 20 | CDK12 | 1.74066163 |
| 21 | LATS1 | 1.69212757 |
| 22 | DAPK2 | 1.67944644 |
| 23 | LMTK2 | 1.65052063 |
| 24 | MAP3K2 | 1.61561068 |
| 25 | PTK6 | 1.57376666 |
| 26 | FGFR1 | 1.54686792 |
| 27 | NEK9 | 1.50268220 |
| 28 | TYRO3 | 1.43574442 |
| 29 | ABL2 | 1.42898156 |
| 30 | NTRK3 | 1.41304435 |
| 31 | FRK | 1.35382623 |
| 32 | FGFR2 | 1.33177097 |
| 33 | JAK2 | 1.30979287 |
| 34 | KDR | 1.30893170 |
| 35 | EIF2AK1 | 1.24529138 |
| 36 | MAP3K7 | 1.16275489 |
| 37 | ERBB2 | 1.15631438 |
| 38 | PRKAA2 | 1.09840032 |
| 39 | JAK1 | 1.09385466 |
| 40 | TESK2 | 1.09244117 |
| 41 | EPHA3 | 1.09031937 |
| 42 | GRK6 | 1.07983864 |
| 43 | EPHB1 | 1.07865583 |
| 44 | TBK1 | 1.03785103 |
| 45 | PINK1 | 1.02180965 |
| 46 | MAP2K3 | 1.01397381 |
| 47 | MAP3K12 | 0.99686057 |
| 48 | MAPK4 | 0.95959619 |
| 49 | MAP3K14 | 0.94951210 |
| 50 | MAP3K10 | 0.93778115 |
| 51 | CSNK1E | 0.91214521 |
| 52 | MET | 0.90990880 |
| 53 | NLK | 0.90297250 |
| 54 | PRKCZ | 0.87781446 |
| 55 | MAP3K3 | 0.84109093 |
| 56 | MAPK15 | 0.82717893 |
| 57 | EPHA2 | 0.81978010 |
| 58 | ACVR1B | 0.81102400 |
| 59 | EIF2AK3 | 0.78668661 |
| 60 | MAPK12 | 0.78351967 |
| 61 | PRKACG | 0.78323185 |
| 62 | MAP3K11 | 0.77386775 |
| 63 | STK38L | 0.77132967 |
| 64 | SCYL2 | 0.76820057 |
| 65 | CDK6 | 0.76518944 |
| 66 | CAMK2G | 0.74817149 |
| 67 | TIE1 | 0.74782669 |
| 68 | CAMK1D | 0.71054261 |
| 69 | RIPK1 | 0.70577126 |
| 70 | KSR2 | 0.69392374 |
| 71 | DYRK1B | 0.69210326 |
| 72 | WNK1 | 0.68876320 |
| 73 | CSNK1D | 0.68658423 |
| 74 | FGFR3 | 0.67899998 |
| 75 | FER | 0.67194092 |
| 76 | CSK | 0.66591505 |
| 77 | GSK3A | 0.66504375 |
| 78 | NEK1 | 0.66292679 |
| 79 | MAPKAPK3 | 0.65438429 |
| 80 | PRKG1 | 0.65437721 |
| 81 | RPS6KB1 | 0.65433554 |
| 82 | PRKAA1 | 0.64880264 |
| 83 | SGK3 | 0.60465995 |
| 84 | MAP2K6 | 0.59021622 |
| 85 | FGR | 0.56906479 |
| 86 | TGFBR2 | 0.56722075 |
| 87 | PTK2 | 0.56521678 |
| 88 | MAPK7 | 0.54856863 |
| 89 | CSF1R | 0.54255200 |
| 90 | IRAK3 | 0.53335095 |
| 91 | IKBKE | 0.53152688 |
| 92 | CSNK2A2 | 0.50877994 |
| 93 | PKN1 | 0.50619149 |
| 94 | PDPK1 | 0.49665383 |
| 95 | PDGFRB | 0.47928356 |
| 96 | PRKCB | 0.47853363 |
| 97 | CSNK2A1 | 0.47810968 |
| 98 | PRKCQ | 0.47063841 |
| 99 | DDR2 | 0.44595336 |
| 100 | SGK1 | 0.44593251 |
| 101 | SGK2 | 0.44576566 |
| 102 | MAP2K1 | 0.44448206 |
| 103 | BCR | 0.43695744 |
| 104 | MAP3K5 | 0.42924163 |
| 105 | IGF1R | 0.42807925 |
| 106 | CSNK1G1 | 0.42666025 |
| 107 | CDK7 | 0.42551474 |
| 108 | GRK1 | 0.42078940 |
| 109 | SRC | 0.42020360 |
| 110 | BRSK2 | 0.41540183 |
| 111 | RET | 0.41414632 |
| 112 | EPHA4 | 0.39764558 |
| 113 | PRKCG | 0.39308340 |
| 114 | PRKACA | 0.38876536 |
| 115 | CDK9 | 0.38507461 |
| 116 | CDK4 | 0.38125727 |
| 117 | MAP3K13 | 0.37879605 |
| 118 | MTOR | 0.37705015 |
| 119 | TAOK2 | 0.37436547 |
| 120 | EGFR | 0.36551515 |
| 121 | PBK | 0.36382651 |
| 122 | ICK | 0.35570276 |
| 123 | MAP3K6 | 0.35173640 |
| 124 | RPS6KA3 | 0.34412339 |
| 125 | NEK6 | 0.34355355 |
| 126 | CAMK4 | 0.31838343 |
| 127 | BRD4 | 0.31688911 |
| 128 | MATK | 0.30769351 |
| 129 | CDC42BPA | 0.30750715 |
| 130 | SGK494 | 0.30698648 |
| 131 | SGK223 | 0.30698648 |
| 132 | MAP3K1 | 0.30467156 |
| 133 | PDK1 | 0.29239560 |
| 134 | IRAK1 | 0.28402022 |
| 135 | PIK3CA | 0.26018657 |
| 136 | PRKCA | 0.25276864 |
| 137 | LATS2 | 0.23781440 |
| 138 | CAMK1G | 0.23182609 |
| 139 | BMX | 0.22558527 |
| 140 | PRKACB | 0.21619694 |
| 141 | ABL1 | 0.21562596 |
| 142 | PAK3 | 0.21514140 |
| 143 | CSNK1G2 | 0.21284157 |
| 144 | MAPK3 | 0.18623073 |
| 145 | CSNK1G3 | 0.18089527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55217005 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75352885 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43995025 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28107544 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.12292718 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93802613 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67569956 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66069775 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63496600 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57729393 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47752136 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34694003 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17694067 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11921067 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08814057 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07058327 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91804995 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89790746 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88955269 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87366255 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86992243 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86522843 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80013081 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76314216 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72307567 |
| 26 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71199910 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68035207 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67678522 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64024109 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63350530 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59398492 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59003435 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56976567 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51478818 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50713967 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47775950 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44872199 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33938540 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33586348 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31428336 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30315912 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26000534 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22562444 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21783137 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21377710 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21190132 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20762145 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12486532 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04911803 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03003083 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00356519 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99704403 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98122846 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95066253 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93967461 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89880357 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89571865 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83575948 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80238322 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78035451 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69426855 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65895676 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65159883 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65141775 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58837920 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53282953 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45346546 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45209062 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44014135 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.40943466 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26573396 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26228375 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24313926 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23891197 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22949346 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20070564 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19966958 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15955928 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13582375 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12634758 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10605957 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.07169737 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01846132 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2434851 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2352632 |
| 86 | Pertussis_Homo sapiens_hsa05133 | -0.2347249 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2240875 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2104474 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2053247 |
| 90 | Lysosome_Homo sapiens_hsa04142 | -0.2043814 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1846701 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1792498 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1750836 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1729152 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1650633 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1570038 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1523234 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1517386 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1483966 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1356163 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1346541 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1246429 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1118101 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1036639 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0829039 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0758002 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0734900 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0572359 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0556234 |

